Milestone Pharmaceuticals Inc. (MIST)

NASDAQ: MIST · Real-Time Price · USD

1.430

-0.030 (-2.05%)

At close: May 19, 2026, 4:00 PM EDT

1.450

+0.020 (1.40%)

After-hours: May 19, 2026, 6:42 PM EDT

Milestone Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	71.32	73.05	25.31	13.76	7.64	114.14
Short-Term Investments	112.9	32.91	44.38	52.24	56.95	-
Cash & Short-Term Investments	184.22	105.96	69.7	66	64.59	114.14
Cash Growth	229.20%	52.03%	5.59%	2.20%	-43.42%	-19.79%
Accounts Receivable	3.15	1.55	-	-	-	-
Other Receivables	1.85	1.96	2.39	3.85	1.21	0.48
Total Trade Receivables	5	3.51	2.39	3.85	1.21	0.48
Inventory	1.83	0.65	-	-	-	-
Other Current Assets	1.21	1.81	1.84	3.18	6.01	4.3
Total Current Assets	192.25	111.92	73.93	73.03	71.8	118.92
Net Property, Plant & Equipment	1.48	1.64	1.57	2.19	2.68	0.93
Total Assets	193.73	113.56	75.5	75.23	74.48	119.85
Accounts Payable	10.02	13.29	7.56	6.68	5.64	6.55
Accrued Expenses	9.8	-	-	-	-	-
Current Portion of Leases	0.66	0.65	0.57	0.55	0.5	0.22
Unearned Revenue	0.42	-	-	-	-	-
Other Current Liabilities	0.04	0.04	-	-	-	-
Total Current Liabilities	20.94	13.98	8.13	7.23	6.14	6.78
Long-Term Debt	136.3	57.19	53.35	49.77	-	-
Long-Term Leases	0.37	0.54	0.87	1.46	2	0.47
Other Long-Term Liabilities	0.07	0.08	-	-	-	-
Total Long-Term Liabilities	136.74	57.81	54.23	51.23	2	0.47
Total Liabilities	157.69	71.79	62.35	58.46	8.14	7.25
Common Stock	373.7	352.62	288.05	260.5	273.9	251.9
Additional Paid-in Capital	119.02	119.75	92.64	82.29	58.79	68.65
Retained Earnings	-456.67	-430.6	-367.55	-326.03	-266.34	-207.95
Shareholders' Equity	36.05	41.77	13.15	16.77	66.35	112.6
Total Liabilities & Equity	193.73	113.56	75.5	75.23	74.48	119.85
Total Debt	137.33	58.38	54.8	51.78	2.49	0.7
Net Cash (Debt)	46.89	47.58	14.9	14.23	62.09	113.44
Net Cash Growth	-1.46%	219.39%	4.71%	-77.09%	-45.26%	-19.75%
Net Cash Per Share	0.47	0.57	0.24	0.33	1.46	2.71
Book Value	36.05	41.77	13.15	16.77	66.35	112.6
Book Value Per Share	0.36	0.50	0.21	0.39	1.56	2.69
Tangible Book Value	36.05	41.77	13.15	16.77	66.35	112.6
Tangible Book Value Per Share	0.36	0.50	0.21	0.39	1.56	2.69

Updated May 13, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q